Computational And Mathematical Methods In Medicine
{"title":"撤回:氟达拉滨、环磷酰胺和利妥昔单抗化学免疫疗法治疗慢性淋巴细胞白血病的数据分析显示患者高度异质性,需要更多考虑个体化治疗。","authors":"Computational And Mathematical Methods In Medicine","doi":"10.1155/2023/9758345","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/7451395.].</p>","PeriodicalId":10591,"journal":{"name":"Computational and Mathematical Methods in Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732791/pdf/","citationCount":"0","resultStr":"{\"title\":\"Retracted: Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment.\",\"authors\":\"Computational And Mathematical Methods In Medicine\",\"doi\":\"10.1155/2023/9758345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This retracts the article DOI: 10.1155/2022/7451395.].</p>\",\"PeriodicalId\":10591,\"journal\":{\"name\":\"Computational and Mathematical Methods in Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732791/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Computational and Mathematical Methods in Medicine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/9758345\",\"RegionNum\":4,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Mathematics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Computational and Mathematical Methods in Medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1155/2023/9758345","RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Mathematics","Score":null,"Total":0}
Retracted: Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment.
[This retracts the article DOI: 10.1155/2022/7451395.].
期刊介绍:
Computational and Mathematical Methods in Medicine publishes research and review articles focused on the application of mathematics to problems arising from the biomedical sciences. Areas of interest include gene therapy, cell kinetics, pharmacokinetics, chemotherapy, oncology, developmental biology, wound healing, physiology, heart modelling, cardiovascular and lung dynamics, neurobiology, computational neuroscience, biomechanics, biomedical statistics, image analysis, epidemiology, immunology, time series analysis, extracellular matrix properties and signalling, and tissue engineering.
The most recent Impact Factor for Computational and Mathematical Methods in Medicine is 1.018 according to 2013 Journal Citation Reports released by Thomson Reuters in 2014.
Computational and Mathematical Methods in Medicine currently has an acceptance rate of 42%. The average time between submission and final decision is 63 days and the average time between acceptance and final publication is 43 days.